1. Home
  2. ALNY
  3. ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on November 21, 2024

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
ALNY

Zacks

3 days ago

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study

Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
ALNY

Clinical Trials Arena

3 days ago

Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment

ALNY

MT Newswires

3 days ago

Alnylam Pharmaceuticals Says Nucresiran Performed Well in Phase 1 Transthyretin Amyloidosis Study

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
ALNY

Business Wire

4 days ago

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

ALNY

Morningstar Research

6 days ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY

MT Newswires

9 days ago

Alnylam Pharmaceuticals Shares Fall After Wolfe Downgrade

ALNY

MT Newswires

9 days ago

Wolfe Downgrades Alnylam Pharmaceuticals to Underperform From Peer Perform, Price Target at $205

3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%
ALNY

Simply Wall St.

9 days ago

3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
ALNY

Pharmaceutical Technology

15 days ago

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

An RNAi renaissance is creating a new generation of startups
ALNY

BioPharma Dive

15 days ago

An RNAi renaissance is creating a new generation of startups

Alnylam to Webcast Presentations at Upcoming November Investor Conferences
ALNY

Business Wire

17 days ago

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

ALNY

Morningstar Research

20 days ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down
ALNY

Zacks

20 days ago

Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down

Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
ALNY

Simply Wall St.

20 days ago

Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
ALNY

GuruFocus.com

20 days ago

Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
ALNY

GuruFocus.com

20 days ago

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight

ALNY

Thomson Reuters StreetEvents

20 days ago

Q3 2024 Alnylam Pharmaceuticals Inc Earnings Call

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say
ALNY

Zacks

21 days ago

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say

Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates
ALNY

Zacks

21 days ago

Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates

ALNY

MT Newswires

21 days ago

Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Net Loss, Revenue Falls

ALNY

Associated Press Finance

21 days ago

Alnylam: Q3 Earnings Snapshot

Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity
ALNY

Business Wire

21 days ago

Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Cognizant signs deal to enhance Alnylam’s IT infrastructure
ALNY

Verdict

22 days ago

Cognizant signs deal to enhance Alnylam’s IT infrastructure

Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024
ALNY

Business Wire

22 days ago

Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024

ALNY

MT Newswires

23 days ago

Cognizant Selected as Alnylam's IT Services Provider

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
ALNY

Zacks

24 days ago

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
ALNY

Zacks

24 days ago

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
ALNY

Zacks

a month ago

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?
ALNY

Zacks

a month ago

Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?

NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B
ALNY

Zacks

a month ago

NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
ALNY

Zacks

a month ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

High Growth Tech Stocks to Watch in October 2024
ALNY

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in October 2024

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?
ALNY

Zacks

a month ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
ALNY

Zacks

a month ago

Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
ALNY

Business Wire

a month ago

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

ALNY

MT Newswires

a month ago

Alnylam Submits Regulatory Application to EMA for ATTR Amyloidosis With Cardiomyopathy Treatment

ALNY

MT Newswires

a month ago

Scotiabank Initiates Alnylam Pharmaceuticals at Sector Outperform With $305 Price Target

Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
ALNY

Business Wire

a month ago

Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
ALNY

Zacks

a month ago

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

3 US Stocks Estimated To Be Trading At Up To 46.6% Discount
ALNY

Simply Wall St.

a month ago

3 US Stocks Estimated To Be Trading At Up To 46.6% Discount

Biotech Eyes Early Entry As Several Factors Could Unleash Shares
ALNY

Investor's Business Daily

a month ago

Biotech Eyes Early Entry As Several Factors Could Unleash Shares

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA
ALNY

Zacks

a month ago

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA

ALNY

MT Newswires

a month ago

Alnylam Pharmaceuticals Files Supplemental New Drug Application With FDA for Vutrisiran

Protein prediction wins chemistry Nobel; Alnylam submits an all-important drug application
ALNY

BioPharma Dive

a month ago

Protein prediction wins chemistry Nobel; Alnylam submits an all-important drug application

Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy
ALNY

Business Wire

a month ago

Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy

RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag
ALNY

Zacks

a month ago

RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy
ALNY

Simply Wall St.

a month ago

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy

Startup led by John Maraganore raises $135M to build ‘future of RNAi’
ALNY

BioPharma Dive

a month ago

Startup led by John Maraganore raises $135M to build ‘future of RNAi’

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
ALNY

BioPharma Dive

a month ago

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Is Expected To Breakeven In The Near Future
ALNY

Simply Wall St.

2 months ago

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Is Expected To Breakeven In The Near Future

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
ALNY

Zacks

2 months ago

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
ALNY

Zacks

2 months ago

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
ALNY

Insider Monkey

2 months ago

Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Says Investigational Drug Slowed ATTR Amyloidosis Progression

Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
ALNY

Business Wire

2 months ago

Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024

Alnylam to Webcast TTR Investor Day
ALNY

Business Wire

2 months ago

Alnylam to Webcast TTR Investor Day

ALNY

MT Newswires

2 months ago

China Merchants Initiates Alnylam Pharmaceuticals at Buy With $360 Price Target

ALNY

MT Newswires

2 months ago

Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says

High Growth Tech Stocks To Watch In September 2024
ALNY

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In September 2024

Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Bullish on This Aggressive Growth Stock
ALNY

Insider Monkey

2 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Bullish on This Aggressive Growth Stock

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Three Stocks That Might Be Undervalued In September 2024
ALNY

Simply Wall St.

2 months ago

Three Stocks That Might Be Undervalued In September 2024

The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly
ALNY

The Wall Street Journal

2 months ago

The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly

Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?
ALNY

Insider Monkey

2 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY Down Despite Positive Data From Heart Disease Drug Study
ALNY

Zacks

3 months ago

ALNY Down Despite Positive Data From Heart Disease Drug Study

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy

Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
ALNY

Investor's Business Daily

3 months ago

Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged

ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam
ALNY

Pharmaceutical Technology

3 months ago

ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam

ESC Congress: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam
ALNY

Pharmaceutical Technology

3 months ago

ESC Congress: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam

Alnylam Stock Falls on Positive but Disappointing Study Results for Heart Drug
ALNY

The Wall Street Journal

3 months ago

Alnylam Stock Falls on Positive but Disappointing Study Results for Heart Drug

Alnylam Plummets, Reversing 50% Gain This Year, As Pfizer Rival Lags Expectations
ALNY

Investor's Business Daily

3 months ago

Alnylam Plummets, Reversing 50% Gain This Year, As Pfizer Rival Lags Expectations

ALNY

MT Newswires

3 months ago

Alnylam Pharmaceuticals Reports Substantial Results of Vutrisiran's Phase 3 Study as Heart Disease Therapy

Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress
ALNY

Business Wire

3 months ago

Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices
ALNY

BioPharma Dive

3 months ago

Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability

Alnylam to Webcast Presentations at Upcoming September Investor Conferences
ALNY

Business Wire

3 months ago

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Alnylam (ALNY) Amvuttra & Givlaari Fuel Revenues Amid Competition
ALNY

Zacks

3 months ago

Alnylam (ALNY) Amvuttra & Givlaari Fuel Revenues Amid Competition

ALNY

MT Newswires

3 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,200,000, According to a Recent SEC Filing

High Growth Tech Stocks To Watch In August 2024
ALNY

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In August 2024

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In August 2024
ALNY

Simply Wall St.

3 months ago

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In August 2024

Here’s Why Alnylam Pharmaceuticals (ALNY) Surged in Q2
ALNY

Insider Monkey

3 months ago

Here’s Why Alnylam Pharmaceuticals (ALNY) Surged in Q2

Investing in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago would have delivered you a 234% gain
ALNY

Simply Wall St.

3 months ago

Investing in Alnylam Pharmaceuticals (NASDAQ:ALNY) five years ago would have delivered you a 234% gain

ALNY

MT Newswires

3 months ago

UBS Raises Alnylam Pharmaceuticals' Price Target to $308 From $288, Buy Rating Maintained

Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 47% Undervaluation?
ALNY

Simply Wall St.

3 months ago

Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 47% Undervaluation?

Alnylam to Present Detailed Results from the HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress 2024
ALNY

Business Wire

3 months ago

Alnylam to Present Detailed Results from the HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress 2024

ALNY

MT Newswires

4 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,089,960, According to a Recent SEC Filing

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY

MT Newswires

4 months ago

Chardan Adjusts Alnylam Pharmaceuticals' PT to $300 From $265, Keeps Buy Rating

Alnylam (ALNY) Up as Q2 Earnings Beat on Collaboration Revenues
ALNY

Zacks

4 months ago

Alnylam (ALNY) Up as Q2 Earnings Beat on Collaboration Revenues

Vir retreats from infectious disease; Vertex shelves AATD drugs
ALNY

BioPharma Dive

4 months ago

Vir retreats from infectious disease; Vertex shelves AATD drugs

ALNY

MT Newswires

4 months ago

RBC Raises Price Target on Alnylam Pharmaceuticals to $300 From $265, Keeps Outperform Rating

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
ALNY

GuruFocus.com

4 months ago

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam (ALNY) Reports Q2 Earnings: What Key Metrics Have to Say
ALNY

Zacks

4 months ago

Alnylam (ALNY) Reports Q2 Earnings: What Key Metrics Have to Say

Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates
ALNY

Zacks

4 months ago

Alnylam Pharmaceuticals (ALNY) Q2 Earnings and Revenues Beat Estimates

ALNY

MT Newswires

4 months ago

Alnylam Pharmaceuticals Swings to Q2 Adjusted Earnings, Revenue Increases

ALNY

Associated Press Finance

4 months ago

Alnylam: Q2 Earnings Snapshot

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock
ALNY

Simply Wall St.

4 months ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity
ALNY

Business Wire

4 months ago

Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity

Share on Social Networks: